ACG CEO, Dennis Petke, Looks forward to having Alliance Growers re-instated for trading in 2022 September 15, 2022 – Vancouver, BC – Alliance Growers Corp. (CSE: ACG; FWB:1LA; OTCPK: ALGWF) (“Alliance Growers” or “the Company) ") announces an update on the Octavia acquisition, a new self-financed opportunity, PharmaGreen and an update on Alliance Growers’ return to trading. Octavia Acquisition Update After months of preparation constructing a new distillery, Octavia received approval by the Liquor and Cannabis Regulation Branch for the location which will allow for production and distribution in both domestic and foreign markets. In the month of August, Octavia received approval for retail sales in Mexico. Octavia Mexico has initiated a digital marketing campaign targeting home and hotel delivery. A new website is in progress, and we expect more updates very soon. Originally announced September 2021, Alliance Growers had entered into a MOU to acquire all the issued and outstanding shares of a private British Columbia based company, Octavia Vodka. The Octavia acquisition includes distillation, filtration and bottling equipment, the bulk of which was purchased new by Octavia in 2020. Under the Alliance umbrella, Octavia will continue to produce and distribute its Premium Octavia Vodka, Espresso Flavoured Octavia Vodka and a Specialty Spirit, all with low-alcohol options. Subject to Canadian and US regulations, Octavia and Alliance will jointly develop, produce and distribute CBD infused spirits under the Octavia brand and other in-house brands, with both low-alcohol and no-alcohol options. As the regulations surrounding the production and distribution of CBD infused spirits in both Canada and the US continue to evolve, management will be working with Octavia and our strategic partners to be ready when the time comes. Given the addition of Octavia Mexico, negotiations are ongoing. Joint Venture/Business Arrangement – Branded European and Canadian Dispensaries The Company has been approached by a private group to develop a structure within Alliance to invest $5 Million into the retail cannabis industry, specifically in European cities that are in the process of allowing the sale of cannabis products for Adult Recreational purposes via regulated dispensaries. The European market has high demand for cannabis related products, and we expect dispensaries there to flourish. Alliance brings various cannabis and hemp expertise as well as a vehicle for raising capital and offering liquidity for its shareholders. The private group brings its own cannabis and hemp expertise in all aspects of operations including regulatory requirements. The group brings a globally recognized and experienced team from the federally regulated Canadian cannabis industry as well as a top tier grow team. They also have celebrity level investors in their company which will benefit the arrangement immensely, creating awareness for the unique branded European and Canadian dispensaries to be developed, featuring their own branded products among others. PharmaGreen Tissue Culture Update Our strategic partner PharmaGreen has made strides in the cannabis space in California to joint-venture on a specialty grow operation coupled with a tissue culture facility including the production of Live Rosin. Alliance Growers holds 1.2 million common shares of PharmaGreen Biotech (OTCQBVenture: PHBI) and has an agreement in place to jointly construct a tissue culture facility in Canada, a plan which will be implemented following the proven results of the California operation. To Learn more about Pharmagreen's strategy to leverage its proprietary cannabis tissue technology, Chibafreen, please visit https://update.pharmagreen.ca/. Alliance to Return to Trading With certain COVID-19 related restrictions being lifted and travel opening up, the Company has been successful in identifying funding that is expected to fund the Company’s trading re-instatement initiatives. Despite many obstacles, the Company continues with business development and with funding gradually coming into place, Alliance Growers is moving forward with the completion of its audits and compliance with all regulatory requirements to return to trading. As previously reported, the Company has expanded its work with its auditors. Given financing delays, Alliance Growers has now further expanded its work with its auditors to complete the August 31, 2020 and August 31, 2021 Annual Financial Statements, together with the interim filings for Q1, Q2 and Q3 for the August 2022 Year End. Management is optimistic that it will complete its audits and other regulatory financial reporting and filings by the end of 2020. Commenting on the Alliance Business opportunities, Dennis Petke, President and CEO of Alliance Growers stated, “We are very pleased to be getting closer to trading while we secure opportunities that are self financed, which will benefit all stakeholders. We thank all our shareholders for their patience.” About Pharmagreen Biotech, Inc. Pharmagreen Biotech, Inc. (OTCQB: PHBI) is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen", to licensed cannabis cultivators and to CBD / CBG hemp farmers. It also provides other value-added services including: plant species identification through DNA testing and certification, live storage of all plant strains using tissue culture, and low temperature storage proprietary technology. The Company is utilizing the best tissue cultured plantlets in its state-of-the-art greenhouse(s) for the highest quality flower tops production. For further information on the company, please visit www.pharmagreen.ca. About Alliance Growers Corp. Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – 1-Products and Services for Cannabis and Hemp Cultivators through its strategic relationship with PharmaGreen Biotech Inc. (PHBI) including the supply of starter plantlets through a proprietary tissue culture process for hemp and cannabis a the supply of feminized, high percentage CBD hemp seeds; 2-Strategic Alliances with Cannabis and Hemp Cultivators, giving the Company access to indoor and outdoor grow facilities and providing hemp and cannabis products (Alliance branded pre-rolls) along with the potential for export of cannabis and hemp product; 3-CBD/THC Infused Products via “self-financed” partnerships including infused spirits and infused health related products; and 4-Research and Technology through strategic relationships with PharamaGreen, its sister company, B.R.I.M., a company with expertise in all aspects of cannabis and hemp and other entities. The Company is in the process of updating its website and company profile with various entities. For further information, please visit the Company’s website at www.alliancegrowers.com or the Company’s profile at www.sedar.com. If you would like to be added to Alliance Growers’ news and newsletter distribution list, please subscribe on the Alliance Website at www.alliancegrowers.com. For more information contact: Rob Grace Communications Consultant Tel: 778-998-5431 RobDGrace@gmail.com Dennis Petke CEO, President and Director Tel: 778-331-4266 DennisPetke@alliancegrowers.com FORWARD LOOKING INFORMATION This news release or newsletter contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. |